Semler Scientific
Agent44Agent Readiness: 44/100. Above median. Measured by StartupHub.ai. Median 41.Develops and markets medical devices for the diagnosis and treatment of peripheral vascular disease.
About
Semler Scientific develops and markets innovative medical technology to support the early detection of chronic diseases, particularly Peripheral Arterial Disease (PAD). Their core product, QuantaFlo, offers providers a portable and easy-to-use solution for point-of-care PAD assessment. The company aims to transform healthcare by enabling earlier diagnosis and better management of chronic conditions.
Similar companies
Develops a brain-computer interface for treating epilepsy.
Shares MedTech, HealthTech
Develops intravascular lithotripsy technology for treating calcified cardiovascular lesions.
Shares MedTech, HealthTech
Medical device company developing and commercializing clot removal devices for venous diseases.
Shares MedTech, Medical Devices
Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.
Shares MedTech, HealthTech
AI-powered EEG device for rapid seizure detection in critical care.
Shares MedTech, HealthTech
Develops an AI-driven surgical navigation platform using 3D ultrasound for enhanced cancer treatment.
Shares MedTech, HealthTech
Key facts
- Website
- semlerscientific.com
- Headquarters
- San Carlos, United States
- Founded
- 2009
- Total funding
- $4M
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2013 | Undisclosed round | $2M | |
| 1 Jan 2012 | Undisclosed round | $2M | |
| 1 Jan 2011 | Undisclosed round | $1M |
Tech stack
Detected on semlerscientific.com, last scanned 21 Sept 2026. Run your own scan
- Observability
- Sentry
- CMS / Builders
- Wix
- Email provider
- Microsoft 365
Frequently asked
How much funding has Semler Scientific raised?
Semler Scientific has raised a total of $4M in funding.
